- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
Monopar Therapeutics (MNPR)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 127.68 mm | 127.68 mm | 127.68 mm | 127.68 mm | 127.68 mm | 127.68 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 1.36 mm | 1.80 mm | 696.84 k | 902.47 k |
| Cash used (since last report) | n/a | n/a | 4.91 mm | 6.48 mm | 2.51 mm | 3.25 mm |
| Cash remaining | n/a | n/a | 122.77 mm | 121.19 mm | 125.17 mm | 124.43 mm |
| Runway (months of cash) | n/a | n/a | 90.0 | 67.3 | 179.6 | 137.9 |
| 13F holders | Current |
|---|---|
| Total holders | 4 |
| Opened positions | 3 |
| Closed positions | 3 |
| Increased positions | 0 |
| Reduced positions | 1 |
| 13F shares | Current |
|---|---|
| Total value | 101.73 mm |
| Total shares | 15.09 k |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Geode Capital Management | 14.07 k | $94.80 mm |
| UBS UBS | 512.00 | $3.45 mm |
| WFC Wells Fargo & Company | 500.00 | $3.37 mm |
| Federation des caisses Desjardins du Quebec | 16.00 | $108.00 k |
| Proequities | 0.00 | $0.00 |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Jan 26 | Patrice Rioux | Stock Option Common Stock | Grant | Acquire A | No | No | 65.3 | 2,000 | 130.60 k | 2,000 |
| 31 Dec 25 | Chandler Robinson | Common Stock | Payment of exercise | Dispose F | No | No | 65.3 | 2,558 | 167.04 k | 85,718 |
| 31 Dec 25 | Chandler Robinson | Common Stock | Option exercise | Acquire M | No | No | 0 | 8,724 | 0.00 | 88,276 |
| 31 Dec 25 | Chandler Robinson | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 8,724 | 0.00 | 113,008 |
| 31 Dec 25 | Andrew Cittadine | Common Stock | Payment of exercise | Dispose F | No | No | 65.3 | 1,889 | 123.35 k | 50,726 |
| 31 Dec 25 | Andrew Cittadine | Common Stock | Option exercise | Acquire M | No | No | 0 | 4,326 | 0.00 | 52,615 |
| 31 Dec 25 | Andrew Cittadine | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 4,326 | 0.00 | 48,267 |
| 26 Dec 25 | Quan Anh Vu | Common Stock | Buy | Acquire P | No | No | 69.95 | 1,500 | 104.93 k | 1,500 |
| 18 Dec 25 | Klausner Arthur J | Common Stock | Sell | Dispose S | No | No | 68.09 | 461 | 31.39 k | 8,762 |
| 18 Dec 25 | Klausner Arthur J | Common Stock | Sell | Dispose S | No | No | 67.06 | 4,660 | 312.50 k | 9,223 |